"MANF Continues to Deliver Heading into 2H-14"
Post# of 30066
Posted On: 06/30/2014 11:01:19 PM
"MANF Continues to Deliver Heading into 2H-14"
"Last week we attended a successful BIO convention where we ended up participating in over 60 partnering meetings , and were extremely pleased with the reception we received from the community at large. It is clear that we have become highly visible to larger pharmaceutical companies , as well as promising early-stage companies seeking to partner their assets. The general theme was that each of our assets has tremendous promise within their own right , and most importantly that there is a strong scientific and business case to be made for each becoming a blockbuster asset . Taken together, the synergies created from a business perspective are able to insulate the Company from significant enterprise risk, and our ability to demonstrate progress with any of these assets will lend credibility to the rest of the portfolio. In light of these comments, we are now especially looking forward to the month of July which includes AAIC and our #C4CT Summit, as well as the rest of 2014. We believe the Company is growing stronger by the day and we are excited to share our enthusiasm with our fellow shareholders."
http://www.thechairmansblog.com/amarantus-bio...ing-2h-14/
"Last week we attended a successful BIO convention where we ended up participating in over 60 partnering meetings , and were extremely pleased with the reception we received from the community at large. It is clear that we have become highly visible to larger pharmaceutical companies , as well as promising early-stage companies seeking to partner their assets. The general theme was that each of our assets has tremendous promise within their own right , and most importantly that there is a strong scientific and business case to be made for each becoming a blockbuster asset . Taken together, the synergies created from a business perspective are able to insulate the Company from significant enterprise risk, and our ability to demonstrate progress with any of these assets will lend credibility to the rest of the portfolio. In light of these comments, we are now especially looking forward to the month of July which includes AAIC and our #C4CT Summit, as well as the rest of 2014. We believe the Company is growing stronger by the day and we are excited to share our enthusiasm with our fellow shareholders."
http://www.thechairmansblog.com/amarantus-bio...ing-2h-14/
(0)
(0)